Home › Funds › Alessandra Capital Management, LLC › PRME

Alessandra Capital Management, LLC position in PRME

PRIME MEDICINE INC · Health Care

Alessandra Capital Management, LLC reported holding 800,773 shares of PRME (PRIME MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 1.72% of its reported portfolio and ranking #12 among its reported holdings. Alessandra Capital Management, LLC has disclosed PRME holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)800.77K sh
Reported value held$2.45M
Portfolio Weight1.72%
First reportedQ1 2026
Last changeAdd
Updated2026-10-31

Last updated: 2026-10-31 · Source: SEC EDGAR Form 13F-HR

How Alessandra Capital Management, LLC's PRME position evolved

Alessandra Capital Management, LLC first disclosed a stake in PRME in Q1 2026 at 425,510 shares (US$1.5M). The position peaked in Q2 2026 at 666,603 shares, worth US$2.5M. Across 3 filings, Alessandra Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 800,773 shares valued at US$2.4M — an increase of 134,170 shares quarter over quarter.. Notable position changes include a 57% increase in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 425.51K $1.48M New
Q2 2026 666.60K $2.46M Add
Q3 2026 800.77K $2.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRME and 13F data

PRME (PRIME MEDICINE INC) is a Health Care company. 36 other funds we track also report a position in PRME — the largest reported positions include Alphabet Inc. (US$61.1M), Casdin Capital (US$11.7M), Redmile Group, LLC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRME

All PRME fund holders →

FAQ

How long has Alessandra Capital Management, LLC held PRME?

Alessandra Capital Management, LLC has disclosed PRME holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Alessandra Capital Management, LLC's current position in PRME?

As of Q3 2026, Alessandra Capital Management, LLC holds 800.77K shares of PRME (PRIME MEDICINE INC), valued at $2.45M, representing 1.72% of its reported portfolio and ranking #12.

Has Alessandra Capital Management, LLC been buying or selling PRME?

In the latest 13F filing (Q3 2026), Alessandra Capital Management, LLC increased its position in PRME. The position peaked in Q2 2026 at 666.60K shares.

Which other funds hold PRME?

Other major institutional holders of PRME include Alphabet Inc., Casdin Capital, Redmile Group, LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.